Stock Market News

US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients (March 5)

Mar 7, 2025 - 19:16
 0
US FDA expands use of ARS Pharma's allergic reaction nasal spray in 15-30 kg patients (March 5)
Read More

Tags:

Previous Article

US to hold hearing on China's efforts to boost semiconductor industry

Next Article

Wolfspeed stock surges on headcount reduction

Related Posts

NYC Mayor Adams seeks permanent dismissal of corruption charges

NYC Mayor Adams seeks permanent dismissal of corruption...

Feb 26, 2025  0

Foxtons shares down after BBG investigative report

Foxtons shares down after BBG investigative report

Feb 26, 2025  0

Gene therapy maker bluebird to go private in discounted deal amid cash crunch

Gene therapy maker bluebird to go private in discounted...

Feb 21, 2025  0